Toll Brothers Delivers Unprecedented Virtual Reality Luxury Home Buying Experience
Jul 27, 2017 13:00 pm UTC| Business
Horsham, PA, July 27, 2017 -- Toll Brothers Inc. (TOL), the nation’s leading builder of luxury homes, announced today it has begun to pilot a new tool to allow home buyers to use virtual reality to envision design...
MKS Announces Release of Series 523 Granville-Phillips® Wide Range Cold Cathode Transducer
Jul 27, 2017 13:00 pm UTC| Business
ANDOVER, Mass., July 27, 2017 -- MKS Instruments, Inc. (NASDAQ:MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced the release of the MKS Granville-Phillips®...
Jul 27, 2017 13:00 pm UTC| Business
ABERDEEN, Wash., July 27, 2017 -- Pacific Financial Corporation (OTCQB:PFLC), the holding company for Bank of the Pacific today reported net income increased 17% to $1.9 million, or $0.18 per share, for the second...
MKS Instruments Announces Upcoming Investor Events
Jul 27, 2017 13:00 pm UTC| Business
ANDOVER, Mass., July 27, 2017 -- MKS Instruments, Inc. (NASDAQ:MKSI), a global provider of technologies that enable advanced processes and improve productivity, announced today that company management will be...
T2 Biosystems Joins Antimicrobials Working Group as First Diagnostic Member
Jul 27, 2017 12:58 pm UTC| Business
LEXINGTON, Mass., July 27, 2017 -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, announced today that it will join the...
Corporate Capital Trust II Invests in First Originated Transaction
Jul 27, 2017 12:57 pm UTC| Business
Orlando, Fla., July 27, 2017 -- Corporate Capital Trust II, a business development company that offers individuals the unique opportunity to invest in the debt of privately owned American companies, recently closed...
Opiant CEO Roger Crystal Appears on Fox & Friends
Jul 27, 2017 12:44 pm UTC| Business
SANTA MONICA, Calif., July 27, 2017 -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and eating disorders, today announced...